About: Dawn Fontaine

Recent Comments by Dawn Fontaine

No comments by Dawn Fontaine yet.

Valerie HardingFollow

The company that has changed the face of PR with its innovative infrastructure & unique pricing structure resulting in lean, yet target-exceeding performance.

Valerie Harding @RippleEffectPR·

1 Jul

Some great insight from Alan Griffiths @Cambashi on which groups will be the Winners vs. the Losers in Covid-19

#COVID19 #IIoT #manufacturingsoftware #analystoutlook

https://connectedworld.com/covid-19-winners-and-losers-in-industrial-iot/

Reply on Twitter 1278426918308757511 Retweet on Twitter 12784269183087575112 Like on Twitter 12784269183087575111 Twitter 1278426918308757511

Valerie Harding @RippleEffectPR·

17 Jun

What an interesting idea! Especially these days, a self-contained car-free city seems like a good option.

#covid19 #gogreen #smartcity
http://ow.ly/YjSU50Aamde

Reply on Twitter 1273279386335219713 Retweet on Twitter 1273279386335219713 Like on Twitter 1273279386335219713 Twitter 1273279386335219713

Valerie Harding @RippleEffectPR·

12 Jun

We at @RippleEffectPR have always said that PR allows you to control the message. It also has a very long shelflife -- especially in the digital age.
#marcom #PR #growyourbusiness

http://ow.ly/F5Wo50A6cp6 https://www.agilitypr.com/pr-news/public-relations/4-ways-using-pr-helps-to-grow-your-business/?utm_campaign=Bulldog%20Reporter&utm_medium=email&_hsmi=89363952&_hsenc=p2ANqtz--NhGfyr02zGxaiu9FxkNcTMOI-cepUDkT8eej9r9Jy6MbntpVrA-mJdRPuAI3Yuqy4h9Owd7l-GeDCh9_3apTpEHFPEQ&utm_content=89363952&utm_source=hs_email

Reply on Twitter 1271468571558895618 Retweet on Twitter 1271468571558895618 Like on Twitter 1271468571558895618 Twitter 1271468571558895618

Valerie Harding @RippleEffectPR·

22 May

Hoping for AstraZeneca to have good news in the next phase of their Covid-19 clinical trial. Amazing that they'd need to produce 1B doses!

#Covid19 #clinicaltrials

http://ow.ly/NHNq50zO8O1 https://www.fiercebiotech.com/biotech/astrazeneca-s-covid-19-vaccine-enters-phase-2-3-clinical-trial?mkt_tok=eyJpIjoiWWpKaFltUXdNVFV5WkRRMyIsInQiOiJQK1laWlQwS0Q4bkdUM0Nla0RPeExac0VxNTQzRVBFbGwzVkhaY0VXbTVNU0w4N25hdTYzZnE5d0JSUEh5NEFnelZ2UU51SWJYMkhMaWpwMTFrWkg2d0FZZk1vR2d0c2hOWFJkbFVucHI1U1wvWmpia2dNSHRlZGdpdVl2RWVScFMifQ%3D%3D&mrkid=965798

Reply on Twitter 1263932839730524161 Retweet on Twitter 1263932839730524161 Like on Twitter 1263932839730524161 Twitter 1263932839730524161

About: Dawn Fontaine

Recent Posts by Dawn Fontaine

BENEO Expands Portfolio with New Organic Ingredients

Introducing the next normal in self-service industrial analytics with Software AG’s TrendMiner 2020.R2 release

TrendMiner wins Plant Engineering Product of the Year Grand Award

Recent Comments by Dawn Fontaine